NHS is too slow to adopt NICE approved treatments, MPs hearBMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e8138 (Published 29 November 2012) Cite this as: BMJ 2012;345:e8138
- Adrian O’Dowd
The NHS is too slow in adopting treatments approved by the drugs watchdog the National Institute for Health and Clinical Excellence, MPs have been told.
Witnesses appearing before the parliamentary health select committee on 27 November said that good guidance from NICE was too often ignored or delayed by commissioners as a way to save money.
MPs, holding an evidence session as part of their inquiry into the institute, asked about implementation of guidance, which provoked different views from the witnesses present.
Laura Weir, chairwoman of Patients Involved in NICE, a coalition group representing more than 80 patients’ groups, said that patients had a legal right to receive drugs and other …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial